Accumulated assignments to resolve when getting clinical studies done in China
For difficulties to conduct clinical studies in China, people picked: devaluation of clinical studies at hospitals, financial opacity and immaturity of the IRB review process.
At the KOREA PHARM & BIO 2018 on the 18th, difficulties that any pharmaceutical company might face before/after entering...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
